Gamma-sarcoglycanopathy

Clinical trials for Gamma-sarcoglycanopathy explained in plain language.

Never miss a new study

Get alerted when new Gamma-sarcoglycanopathy trials appear

Sign up with your email to follow new studies for Gamma-sarcoglycanopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New study aims to map rare muscle disease progression

Knowledge-focused Cancelled

This study was designed to track the natural course of gamma-sarcoglycanopathy (LGMDR5), a rare muscle-weakening disease, over two years. Researchers planned to measure changes in muscle strength, walking ability, and daily function in patients aged 6 to 35. The goal was to bette…

Matched conditions: GAMMA-SARCOGLYCANOPATHY

Sponsor: Atamyo Therapeutics • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:54 UTC

Gamma-sarcoglycanopathy

Get alerted when new Gamma-sarcoglycanopathy trials appear

New study aims to map rare muscle disease progression